ArticleJournal of applied clinical medical physics2026
Quantifying variation in DLP- to- effective-dose conversion factors in CT using a Monte Carlo-based dose-estimation software.
Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA common method to estimate the effective dose in CT is to multiply the dose length product in a CT scan by a conversion factor (k). The k-factors are determined by dividing the effective dose (calculated using a weighted summation of organ doses) by the dose length product (DLP) for specific digital phantoms. The k-factors determined in this way may vary substantially depending on the effective dose calculation methods and phantom models used. PURPOSE: The purpose of this study was to estimate variation associated with different acquisition and patient characteristics in the quantification of k-factors.
methodsK-factors were calculated using VirtualDoseCT for a diverse set of computational phantoms representing different patient models, scanner models, and seven CT exams. The tube potential varied from 80 to 120 kV. The scan length was varied by ± 5 cm relative to the default setting. The CTDIvol was set to 10 mGy when tube current modulation was not used; otherwise, the software default was used. A multivariable regression method was employed to derive an empirical formula for k-factors, along with model-uncertainty analysis and Sobol's sensitivity analysis to identify the influence of each variable.
resultsK-factors for all exams increased with kV. Negative dependence of k-factors on BMI was observed, with lower values in males than in females. Moderate to high variation was observed in the quantification of k-factors without TCM, which remained unchanged with TCM. Based on Sobol's indices (0.8-1), k-factors were influenced most by scan length and patient size for adults, and scan length and age for pediatric phantoms. DISCUSSION: The study showed that a large spread in k-factors was predominantly influenced by scan length, patient size and age. The heterogeneity in k-factors may lead to large heterogeneity in the effective dose estimate if the DLP×k method is used. These results indicate that age and size specific k-factors to estimate effective dose from DLP may be warranted.
conclusionsA set of k-factors should be established to account for these factors and improve effective dose estimations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.